Willow Biosciences Inc.

TSX:WLLW Stock Report

Market Cap: CA$1.4m

Willow Biosciences Management

Management criteria checks 2/4

We currently do not have sufficient information about the CEO.

Key information

Travis Doupe

Chief executive officer

CA$328.2k

Total compensation

CEO salary percentage89.0%
CEO tenure6.1yrs
CEO ownership1.4%
Management average tenureno data
Board average tenure4.2yrs

Recent management updates

Recent updates

Is Willow Biosciences (TSE:WLLW) In A Good Position To Deliver On Growth Plans?

Apr 11
Is Willow Biosciences (TSE:WLLW) In A Good Position To Deliver On Growth Plans?

We Think Willow Biosciences (TSE:WLLW) Needs To Drive Business Growth Carefully

Dec 20
We Think Willow Biosciences (TSE:WLLW) Needs To Drive Business Growth Carefully

We Think Willow Biosciences (TSE:WLLW) Can Afford To Drive Business Growth

Sep 02
We Think Willow Biosciences (TSE:WLLW) Can Afford To Drive Business Growth

We Think Willow Biosciences (TSE:WLLW) Can Easily Afford To Drive Business Growth

May 20
We Think Willow Biosciences (TSE:WLLW) Can Easily Afford To Drive Business Growth

Calculating The Fair Value Of Willow Biosciences Inc. (TSE:WLLW)

Jan 19
Calculating The Fair Value Of Willow Biosciences Inc. (TSE:WLLW)

CEO Compensation Analysis

How has Travis Doupe's remuneration changed compared to Willow Biosciences's earnings?
DateTotal CompensationSalaryCompany Earnings
Dec 31 2024CA$328kCA$292k

-CA$6m

Sep 30 2024n/an/a

-CA$8m

Jun 30 2024n/an/a

-CA$9m

Mar 31 2024n/an/a

-CA$11m

Dec 31 2023CA$377kCA$285k

-CA$13m

Sep 30 2023n/an/a

-CA$15m

Jun 30 2023n/an/a

-CA$17m

Mar 31 2023n/an/a

-CA$17m

Dec 31 2022CA$470kCA$275k

-CA$15m

Sep 30 2022n/an/a

-CA$15m

Jun 30 2022n/an/a

-CA$7m

Mar 31 2022n/an/a

CA$2m

Dec 31 2021CA$707kCA$268k

-CA$6m

Sep 30 2021n/an/a

-CA$16m

Jun 30 2021n/an/a

-CA$27m

Mar 31 2021n/an/a

-CA$44m

Dec 31 2020CA$311kCA$245k

-CA$34m

Sep 30 2020n/an/a

-CA$22m

Jun 30 2020n/an/a

-CA$16m

Mar 31 2020n/an/a

-CA$45m

Dec 31 2019CA$723kCA$174k

-CA$45m

Compensation vs Market: Travis's total compensation ($USD238.30K) is above average for companies of similar size in the Canadian market ($USD169.82K).

Compensation vs Earnings: Travis's compensation has been consistent with company performance over the past year.

CEO

Travis Doupe (53 yo)

6.1yrs

Tenure

CA$328,153

Compensation

Mr. Travis Doupe is the Chief Financial Officer of Willow Biosciences Inc. since April 12, 2019 and serves as Interim Chief Executive Officer from April 30, 2025. He has been Chief Financial Officer and Vi...

Board Members

NamePositionTenureCompensationOwnership
Donald Archibald
Independent Director6.1yrsCA$25.00k1.29%
CA$ 18.7k
James Lalonde
Independent Chairman2.3yrsCA$55.00k0.27%
CA$ 3.9k
Albert Foreman
Director6.1yrsCA$20.00k0.049%
CA$ 709.2
Raffi Asadorian
Independent Director2yrsCA$25.00k0.0046%
CA$ 66.6

4.2yrs

Average Tenure

59yo

Average Age

Experienced Board: WLLW's board of directors are considered experienced (4.2 years average tenure).

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/05/06 13:16
End of Day Share Price 2025/05/06 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Willow Biosciences Inc. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
David KideckelATB Capital Markets